findmyKOL
Clinical trialNCT03914794CompletedPhase 2Interventional

A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

SponsorSidney Kimmel Comprehensive Cancer Center at Johns HopkinsEnrollment30Bladder CancerNMIBCNon-Muscle Invasive Bladder CancerUrothelial Carcinoma Recurrent
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Noah M Hahn, MD

    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Sibley Memorial Hospital

    Washington D.C., District of Columbia, United States

  • Johns Hopkins School of Medicine - Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland, United States

  • Associated Medical Professionals Urology

    Syracuse, New York, United States

  • Midlantic Urology

    Bala-Cynwyd, Pennsylvania, United States

  • Keystone Urology

    Lancaster, Pennsylvania, United States

  • Carolina Urologic Research Center

    Myrtle Beach, South Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Oct 2020
Primary completion
30 Sept 2025
Completion
30 Sept 2025
Last update posted
3 Oct 2025
Registered enrollment
30
Registry id
NCT03914794

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.